🔗 Share this article

A shadow market for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Investigational Drug Gaining Popularity Via Social Media

Retatrutide, which is still in research studies, is being advertised by online personalities for its supposed fat-burning properties. Viewers are urged to message these profiles directly for supplier links, while also receiving discount codes.

Active Commerce on Social Networks

Additionally, a robust trade exists on messaging services, where communities with thousands of members share comparison images, administration instructions and claims of next-day British shipping. Sellers promote the substance there before redirecting buyers to WhatsApp for transactions.

Learning About The Experimental Drug

This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Experts Voice Worries

However, doctors and pharmacists have cautions that the sale of what remains an unlicensed drug in the UK is worrisome and could result in individuals injecting substances of uncertain source.

Some experts said the demand for retatrutide could be linked to the rising cost of approved weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still breach medicines, marketing, and consumer laws, potentially leading to penalties, prosecution or prison.

Service Reaction and Material Removal

According to the social media company, the service has taken down violative material and banned related hashtags and query recommendations. The organization stated it was committed to maintaining the service secure and investing in strengthening compliance measures.

Online Trading Operations

Research also discovered communities with up to 9,000 members marketing the experimental drug using Telegram's integrated search feature, which functions like a public directory. Entering “retatrutide” instantly displays groups with thousands of members, filled with photos of slimming results, glowing testimonials and detailed instructions for mixing or injecting at home.

Within minutes of entering one community, a seller shared WhatsApp details, where the majority of transactions occur. The seller sent an instruction manual and guaranteed delivery within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about weight, medical conditions or past usage.

Product Details and Costs

Within these communities, messages display dark colored packages with Royal Mail stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with purified liquid, or ready-to-use pens typically sold at £160 for 20 milligrams. When questioned how long a injector should be used, sellers give conflicting responses varying between a several days to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for the messaging service said it regularly monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering substances they cannot confirm. Although the science behind this drug is valid, these digital products may not contain what they advertise,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the surge in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With prices rising, individuals are turning to social media. But fake treatments are highly dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.

Her team has previously encountered individuals harmed by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your health,” said the doctor. “These substances could be contaminated or improperly measured.”

Producer Statement

A spokesperson from Eli Lilly stated retatrutide was in third stage research studies and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company investigational product not yet authorized … may expose users to possibly serious health risks”.